• Explore /
  • Poster
  • / PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.

PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.

Abstract Poster

Authors

null

Mererid Evans

Velindre NHS Trust, Cardiff, United Kingdom

Mererid Evans , Sarah Knott , Chris Hurt , Joanne Patterson , Max Robinson , Kate A. Hutcheson , Lisette Nixon , Matthew Beasley , Jonny Lee , Wendy Wade , Nachi Palaniappan , Christian Simon , Ned Powell , William Greenhalf , Terry Jones

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT02215265

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS6097)

DOI

10.1200/JCO.2018.36.15_suppl.TPS6097

Abstract #

TPS6097

Poster Bd #

81b

Abstract Disclosures

Similar Posters

First Author: Heath Devin Skinner

First Author: Hillary Sloane

First Author: Toon Van Gorp

First Author: Linda X Yin